Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weng, N.-p.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weng, N.-p.
(Journal of Leukocyte Biology. 2001;70:861-867.)
© 2001 by Society for Leukocyte Biology

Interplay between telomere length and telomerase in human leukocyte differentiation and aging

Nan-ping Weng

Laboratory of Immunology, National Institute on Aging, National Institutes of Health, Baltimore, Maryland

Correspondence: Dr. Nan-ping Weng, Laboratory of Immunology, National Institute on Aging, NIH, 5600 Nathan Shock Drive, Box 21, Baltimore, MD 21224. E-mail: wengn{at}grc.nia.nih.gov


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 HEMATOPOIETIC STEM CELLS
 LYMPHOID LINEAGE
 MYELOID LINEAGE
 CONCLUSION
 REFERENCES
 
Blood leukocytes derive from bone marrow hematopoietic stem cells and differentiate into multiple types of mature cells that include granulocytes, monocytes, mast cells of myeloid lineage, and T and B lymphocytes of lymphoid lineage. Their distinctive paths of differentiation and unique roles in immune response provide a model for comparative analysis of biological parameters, such as telomere length and telomerase activity, in different types of leukocytes. Age has also been associated with the decline in immune functions and with the attrition of telomere length in leukocytes. This review will summarize recent progress in the study of telomere length and telomerase expression in leukocytes during differentiation and aging. In addition, I will attempt to shed new light on the roles of telomere and telomerase in leukocyte function and potential clinical interventions.

Key Words: lymphocyte • monocyte • granulocyte • mast cells


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 HEMATOPOIETIC STEM CELLS
 LYMPHOID LINEAGE
 MYELOID LINEAGE
 CONCLUSION
 REFERENCES
 
Leukocytes are composed of different types of cells that derive from the hematopoietic stem cells in the bone marrow (BM) and circulate in blood and tissues executing innate and adaptive immune functions. Based on the known progenitor cells, blood leukocytes can be mainly separated into myeloid and lymphoid lineages. The myeloid progenitor gives rise to granulocyte (neutrophil, eosinophil, and basophil), monocyte/macrophage, and mast cells, which serve largely in the innate immune response. Lymphoid progenitor gives rise to T (CD4+ and CD8+) and B lymphocytes and natural killer (NK) cells, which are mainly responsible for adaptive immune response.

Each type of leukocyte has a distinct differentiation and maturation process. The myeloid progenitor cells differentiate in the BM to become granulocyte, monocyte, and mast cell and then migrate into the peripheral blood with a relative short lifespan (hours to days) [1 ]. Lymphoid progenitor cells also differentiate in BM. However, only B lymphocytes mature in BM [2 ], whereas T lymphocytes mature in the thymus [3 ]. Mature, naïve B and T lymphocytes have a much longer lifespan than myeloid-derived mature cells [4 ].

Mature leukocytes circulate in blood and exhibit characteristic patterns of growth, migration, and cellular function. Myeloid-derived, mature leukocytes are terminally differentiated cells and do not undergo further cell division. Mature lymphocytes, however, retain the ability for a rapid proliferation and differentiation, producing a large number of cells upon antigenic stimulation. Some activated lymphocytes become long-lived memory cells that are capable of further, extensive cell divisions upon reencounter of specific antigen. Thus, dependence on cellular replicative capability is one of the key differences in the function of myeloid- and lymphoid-derived cells.

The lifespan of cells may be regulated by multiple factors. Recently, telomeres and telomerase have been implicated for their roles in regulating replicative lifespan. Telomeres are special structures located at the end of eukaryotic chromosomes, which consist of an array of tandem heximer DNA repeats (TTAGGG)n and associated proteins. Constraints on the ability of DNA polymerase to completely replicate the extreme 3' end of chromosomes lead to a loss of telomere repeats and have been observed in human somatic cells with cell division [5 , 6 ]. It has also been suggested that telomeres can change from a normal "capped" state to an abnormal "uncapped" state [7 ]. The numbers of uncapped telomere ends increase in cells with critically short telomeres, which can signal cells to enter cell-cycle arrest or senescence. Thus, telomere length and its states serve as a biological regulator underlying the limited division potential of human cells.

Telomerase is a ribonucleoprotein enzyme that can synthesize telomeres and compensate for the cell division-associated loss of telomeres. Although not all the components of telomerase holoenzyme have been identified, the core components of telomerase consist of telomerase-reverse transcriptase [8 , 9 ] and telomerase RNA template [10 ]. The expression of telomerase is highly regulated during development and differentiation in a tissue-specific manner. Many tissues express telomerase only during development and differentiation, but lose expression in terminally differentiated or mature cells. However, germ cells and some stem cells retain expression of telomerase. This phenomenon has been attributed to the fact that most terminally differentiated cells do not require substantial cell divisions for their function and that unregulated telomerase may facilitate the transformation of normal cells. Recent studies showed that telomerase is expressed in stem cells [11 , 12 ], stem-like cells (such as basal-layer cells in the skin and intestine-endothelial cells) [13 , 14 ], and lymphocytes [15 , 16 ]. The questions of how telomere length is regulated in cells that express telomerase and whether telomerase expression extends the replicative lifespan of these cells remain controversial.

Age associated with decline of the overall cellular function has been demonstrated in innate and adaptive immune responses [17 18 19 ]. Changes with aging include a decrease in production of hematopoietic stem cells [20 ], clonal or oligoclonal expansion of CD28- T cells [21 ], and intrinsic defects in cellular function of leukocytes [22 ]. Because the function of the immune system is highly dependent on the capacity for extensive cell division and clonal expansion of lymphocytes, it is of great interest to understand if age-related processes result in a loss of the replicative capacity of lymphocytes. In this review, I will summarize the recent studies on telomere length and telomerase expression in human leukocytes during differentiation and aging.


    HEMATOPOIETIC STEM CELLS
 TOP
 ABSTRACT
 INTRODUCTION
 HEMATOPOIETIC STEM CELLS
 LYMPHOID LINEAGE
 MYELOID LINEAGE
 CONCLUSION
 REFERENCES
 
Germ cells can maintain or even lengthen telomeres through expression of telomerase [23 , 24 ]. Hematopoietic stem cells as the descendents share significant similarity with germ cells. Sustained proliferation of hematopoietic stem cells is required for hematopoiesis throughout life. It is therefore of considerable interest to understand whether similar protection mechanisms are operating in hematopoietic stem cells as in germ cells. Vaziri et al. [25 ] described an analysis of telomere length in hematopoietic stem cells (CD34+CD38lo). They found that telomeres are shorter in stem cells purified from adult BM than from fetal liver or umbilical cord blood (CB) and that BM stem cells have longer telomeres in young donors than in old donors. Engelhardt et al. [26 ] also found that average telomere lengths of CD34+ cells were 10.4 kb in CB, 7.6 kb in BM, and 7.4 kb in peripheral blood.

There is an accumulating body of data derived from comparative analyses of telomere length of leukocytes between donor and recipient after BM transplantation (BMT) with hematopoietic stem cells [27 28 29 30 31 32 33 34 ]. To reconstitute the hematopoietic systems in the recipients, the donor hematopoietic stem cells must undergo extensive cell divisions to generate a sufficient number of cells. Notaro et al. [27 ] compared telomere length in granulocytes between donor and recipient of 11 BMT pairs and found a significant loss of telomere length in the recipients. Wynn et al. [28 , 29 ] compared telomere length in leukocyte, neutrophil, and T cells of 28 BMT cases and also found loss of telomeres in the recipients. Although different types of leukocytes were analyzed in the different studies, various degrees of telomere shortening were observed in all studies. Together, these results suggest that unlike germ cells, hematopoietic stem cells appear to lose telomere length with cell division and age (Fig. 1 ).



View larger version (9K):
[in this window]
[in a new window]
 
Figure 1. Telomere shortening with age in hematopoietic-derived and germ cells. In contrast to stable telomere length in germ cells (solid green line) through age, all hematopoietic-derived cells display telomere shortening with age. Hematopoietic stem cells (solid red line) have longer telomeres than those in cells from lymphoid (dotted yellow line) and myeloid (solid blue line) lineages. The difference in telomere length among these four types of cells reflects the loss of telomeres during their differentiation. The pattern of telomere loss in hematopoietic stem cells and in lymphocytes with age is similar: Loss or gain of telomere length with age is determined by the levels of telomerase activity in these cells. Myeloid cells (granulocytes) display a continuous loss of telomere length, which may reflect the loss of telomeres in myeloid progenitor cells.

 
Despite telomere shortening with age and cell divisions, hematopoietic stem cells appear to express telomerase in a regulated manner. Morrison at el. [11 ] assayed telomerase activity in BM hematopoietic stem cells at various differentiation stages and found that the frequency of telomerase-expressing cells within each population was proportional to the frequency of cells thought to have self-renewal potential (Fig. 2 ). Approximately 70% of BM hematopoietic stem cells exhibited detectable telomerase activity, suggesting that self-renewal potential is closely associated with telomerase activity [35 ]. Similar findings were also demonstrated by Chui et al. [12 ], who showed that high levels of telomerase activity were detected in the early progenitors (CD34+CD71+) and low levels of telomerase activity in primitive hematopoietic stem cells (CD34+CD71loCD45RAlo). In addition, Yui et al. [36 ] observed an increase in telomerase activity in candidate hematopoietic stem cells (CD34+) from adult BM when they were cultured in the presence of stem cell factor (SCF), interleukin-3 (IL-3), and Flt3-ligand (FL). Within the CD34+ fraction of the cultured cells, significant activity was found in the CD34+CD71+ fraction.



View larger version (29K):
[in this window]
[in a new window]
 
Figure 2. Telomerase expression during hematopoietic-derived cell differentiation. Telomerase expression is highly regulated during development of hematopoietic cells. Telomerase is expressed during development in lymphoid and myeloid cells but down-regulated in mature, resting lymphoid and myeloid cells. In contrast to mature myeloid-derived cells that do not express telomerase after activation, mature lymphocytes are capable of expressing telomerase after antigenic stimulation.

 
Together, these results suggest that telomere length and telomerase expression are highly regulated in hematopoietic cells. Unlike germ cells, loss of telomeres is evident in hematopoietic stem cells with cell division and with aging. Hematopoietic stem cells may be capable of maintaining telomeres when telomerase activity is high, and such protection may be lost once telomerase activity is low. Further studies will need to understand the regulatory mechanisms of telomerase expression and its functional roles in telomere maintenance in these exceedingly important hematopoietic cells.


    LYMPHOID LINEAGE
 TOP
 ABSTRACT
 INTRODUCTION
 HEMATOPOIETIC STEM CELLS
 LYMPHOID LINEAGE
 MYELOID LINEAGE
 CONCLUSION
 REFERENCES
 
The attrition of telomere length has been observed in peripheral blood T and B lymphocytes with age in vivo and with cell division in vitro [37 , 38 ]. At the same time, telomerase was detected in lymphocytes during development, differentiation, and activation [39 ]. Although the precise functional relationship between telomere length regulation and telomerase expression in lymphocytes remains to be elucidated, there have been some attempts to understand how telomerase is regulated and what role it plays in telomere maintenance and replicative lifespan in lymphocytes. Because there are no studies regarding telomere length and telomerase expression in NK cells, the relationship between telomere length and telomerase expression will be discussed only in T and B lymphocytes.

T lymphocytes
Telomere shortening has been found in blood CD4+ and CD8+ T cells with age in vivo [37 , 38 , 40 ] and with cell division in vitro [37 ]. Son et al. [38 ] demonstrated a cross-sectional analysis of CD4+ T cells of 121 normal donors aged from newborn to 94 years and showed that the rates of telomere shortening of CD4+ and CD8+ T cells are 35 and 26 bp/year, respectively. Although telomere loss appears to continue through life, Rufer et al. [40 ] found that there was rapid loss of telomeres in the first year of life at a rate that is 30-fold higher than that in the subsequent nine decades. Recently, Friedrich et al. [41 ] showed changes in telomere length of leukocytes during human fetal development. They found a rapid and significant decline in mean telomeric restriction fragment length between 27 and 32 weeks of gestation (P=0.02, r=0.79), followed by a period of no significant loss of telomere repeats between 33 and 42 weeks of gestation. In addition to telomere loss under normal development and aging, an accelerated loss of telomeres was observed under an abnormal condition in vivo. T cells from Down syndrome patients showed a significantly higher rate of telomere loss with donor age (133±15 bp/year) compared with age-matched controls (41±7.7 bp/year; P<0.0005) [42 ].

Because the length of telomeres reflects past cell division of a cell, it may be useful for assessing the potential precursor and descendent relationship within a single lineage of cells. The first such analysis was done in naïve and memory CD4+ T cells from a group of 20 donors aged from 25–70 years [37 ]. It was found that telomere length measured by the mean terminal restriction fragments (TRF) length was 1.4 kb longer in naive CD4+ T cells than in memory T cells from the same donors and that this difference remained constant over a wide range of donor ages [37 ]. The rate of loss of telomeres with age was similar between naïve and memory CD4+ T cells (approximately 33 bp/year). A subsequent, more extensive analysis by Rufer et al. [40 ], using a much larger cohort (over 500 donors aged from 0–90 years), confirmed that naïve CD4+ T cells have consistently longer mean telomere length than memory CD4+ T cells. The rate of telomere loss in that study, however, was slightly greater in memory CD4+ T cells (51 bp/year) than in naïve CD4 T cells (39 bp/year) with age. Burns et al. [43 ] extended the telomere length analysis to memory T cells responding to tetanus toxoid and Candida albicans. They found that Candida- or tetanus-reactive memory T-cell populations demonstrated a significant reduction of telomere length even when compared with the phenotypically defined memory CD45RO+ T-cell populations isolated from peripheral blood mononuclear cells (PBMC) [43 ].

Similar findings of telomere length differences were also observed in CD8+ T-cell subsets. Monteiro et al. [44 ] showed that CD8+CD28- T cells have shorter telomeres compared with CD8+CD28+ T cells [45 ]. Rufer et al. [40 ] also showed that naïve CD8+ T cells have longer telomeres than memory CD8+ T cells. These findings suggest that the differentiation of memory cells from naive precursors occurs with substantial cell division. Thus, telomere length could be a useful marker for determining the precursor/descendent relationship within a cell lineage.

The cross-sectional analysis of age-associated telomere shortening implies that accumulating cell divisions in vivo with age may be the cause for the telomere loss. A more direct assessment of such a relationship was carried out by culturing primary T cells over 3–4 months in vitro. Cell division was estimated by the calculation of mean population doublings (MPD) in parallel with the measurement of telomere length changes. Analysis of long-term, cultured naïve and memory CD4+ T cells found that naïve and memory CD4+ T cells lose telomeres during the course of long-term culture. The rate of telomere loss per cell division ranged from 50–100 bp/year in naive and memory CD4+ T cells. It is interesting that naive CD4+ T cells that have longer telomeres undergo a greater number of MPD than memory CD4+ T cells [37 ]. Similarly, long-term, cultured CD8+ T cells also lost telomere length with cell divisions [46 ]. Thus, CD4+ and CD8+ T cells appear to lose telomere length with cell division in vitro. However, it is not clear whether the cease of cell division in the end of long-term culture results from an exhaustion of the division potential or lack of proper growth conditions. Therefore, longitudinal analyses of lymphocytes ex vivo and in vitro with optimized culture conditions will be necessary in order to understand the mechanisms of telomere length regulation and its role in lymphocyte replicative lifespans.

Considering the importance of cellular replicative capability in lymphocyte function, it is conceivable that some telomere protection mechanisms may work in lymphocytes. The first evidence that lymphocytes might express telomerase was from stuides by Broccoli et al. and others [15 , 16 ]. Both showed that a low level of telomerase was detected in peripheral blood lymphocytes isolated from normal donors. Subsequent analysis found that telomerase activity is highly regulated during T-cell development and differentiation. High levels of telomerase were detected in thymocytes [39 ] and low-to-undetectable levels in mature CD4+ and CD8+ T cells. It is intriguing that telomerase activity can be induced in these mature CD4+ and CD8+ T cells after in vivo antigenic stimulation or in vitro activation [39 , 47 , 48 ]. These findings indicate that human telomerase is not restricted to immortal or germ cells and specifically raise questions of the functional role of telomerase in lymphocytes and of aging influence in telomerase expression.

Although the precise role of telomerase in lymphocyte function remains to be elucidated, several studies showed that the levels of telomerase activity in lymphocytes appear to correlate with the telomere states in cultured lymphocytes [46 , 49 ]. Studies of long-term cultured CD4+ and CD8+ T cells show that telomere length was stable when telomerase activity was high, whereas telomere length shortened when telomerase activity was low-to-undetectable. Recent longitudinal analyses of cytotoxic CD8+ T-cell responses against Epstein-Barr virus (EBV) in vivo show that EBV-specific CD8+ T cells in patients with acute infectious mononucleosis (AIM) undergo considerable expansion without telomere length loss and that these cells express high levels of telomerase activity [50 , 51 ]. Thus, it appears that there is a quantitative relationship between telomerase activity and maintenance of telomere length in lymphocytes. Understanding how telomerase is regulated will undoubtedly help to elucidate telomere length dynamics in lymphocytes and may provide new means of immunomodulation for clinical intervention.

To determine whether age affects telomerase expression in lymphocytes, Son et al. [38 ] recently demonstrated a cross-sectional analysis of telomerase induction. They showed that age did not appear to alter the magnitude of telomerase activity induced after stimulation of CD4+ and CD8+ T lymphocytes through T-cell receptor (TCR) and costimulatory receptors or in response to phorbol 12-myristate 13-acetate (PMA) plus ionomycin treatment in a 3-day culture [38 ]. These findings suggest that the capacity for telomerase expression may be stable and does not change with age in CD4+ and CD8+ T lymphocytes. It remains to be determined, however, whether sustained induction of telomerase activity changes with age.

B lymphocytes
Despite the many similarities between T and B lymphocytes, the latter display some unique features in regulation of telomere length and telomerase activity. Like T lymphocytes, B lymphocytes lose telomeres with age, but the rate of telomere attrition appears to be slower than T cells (19 bp/year for B cells compared with 30–50 bp/year for T cells) [38 ]. Although there is no available method for growing normal B lymphocytes for the long term, a study using EBV-immortalized B cells showed that telomere shortening occurs with cell division in these B cells in vitro [8 ]. One striking difference between T and B lymphocytes is in relative telomere lengths in their subsets. Unlike naïve and memory T cells, there is no obvious telomere shortening in memory B cells compared with naïve B cells isolated from tonsil. In contrast, germinal center (GC) B cells as the descendent of naïve B cells have significantly longer telomeres than naïve or memory B cells. Although there is no study of telomere length in peripheral blood naïve and memory B cells to directly compare with T cells, these findings suggest that regulation of telomere length in B lymphocytes may differ from T lymphocytes.

Like T lymphocytes, telomerase activity was lower-to-undetectable in resting, mature B lymphocytes freshly isolated from peripheral blood than was induced upon activation through B cell receptor, by superantigen, or by PMA/ionomycin [52 53 54 ]. An in vivo example of telomerase regulation in response to B-cell activation is found in GC B cells that have presumably differentiated from naïve B cells after antigenic activation and that express high levels of telomerase activity [53 ]. Although induction of telomerase activity in resting lymphocytes has been correlated with antigen receptor activation-induced cellular proliferation, Hu et al. [54 ] showed that proliferation of B lymphocytes induced by cytokines did not activate telomerase. Thus, it appears that the events of telomerase activation and cellular proliferation can be regulated independently. In addition, age does not appear to alter the magnitude of telomerase activity induced after in vitro stimulation of B lymphocytes through Ag and costimulatory receptors or in response to PMA plus ionomycin treatment [38 ].

The relationship of telomerase expression and telomere loss in B lymphocytes has been shown during B-cell differentiation [52 ]. In contrast to previous observations of telomere attrition during the process of somatic cell differentiation and cell division, GC B cells had significantly longer telomeres than those of precursor naive B cells, which were correlated with high levels of telomerase expression. These results suggest that telomerase may not only preserve but also lengthen telomeres in actively dividing GC B cells. Thus, telomerase may play a critical role in humoral immune response by maintaining the replicative potential of GC and descendant memory B cells.


    MYELOID LINEAGE
 TOP
 ABSTRACT
 INTRODUCTION
 HEMATOPOIETIC STEM CELLS
 LYMPHOID LINEAGE
 MYELOID LINEAGE
 CONCLUSION
 REFERENCES
 
Myeloid lineage cells are primarily responsible for innate immune response and have short lifespans and high turnover rates. The shortening in length with age of telomere and the expression of telomerase during differentiation in myeloid lineage have been analyzed recently. Telomerase regulation in myeloid progenitor cells may have great impact on the production of myeloid lineage cells, granulocyte, monocyte, and mast cells.

Granulocytes
Granulocytes are a group of leukocytes that include neutrophils, basophils, and eosinophils. Unlike lymphocytes, mature granulocytes do not undergo cell division; therefore, telomere length of granulocytes reflects myeloid progenitor cells. Rufer et al. [40 ] described an analysis of 301 normal donors aged from 0–90 years and found that an overall loss of telomere length in granulocyte with age is approximately 39 bp/year. Like T lymphocytes, granulocytes also display a rapid loss of telomere length in the first year of life [40 , 55 ]. It is interesting that the difference in telomere length between granulocytes and T lymphocytes in peripheral blood appears to be influenced by age [29 , 40 ]. Telomeres were generally shorter in granulocytes than in T lymphocytes from young donors, whereas telomere was longer in granulocytes than in T lymphocytes in aged individuals. This reversal of telomere length between granulocytes and T lymphocytes with age may reflect a significant increase of memory T lymphocytes that have shorter telomeres than those in naïve T lymphocytes in the elderly.

Telomerase expression in granulocytes is controversial. One study suggested that there was a low level of telomerase activity in the granulocyte fraction from peripheral blood [15 ]. However, subsequent studies failed to detect telomerase activity in granulocytes [56 57 58 59 ]. It is possible that a residual contamination of stem cells or lymphocytes in the granulocyte fraction contributes to the low activity of telomerase. Physiologically, it seems unlikely that mature granulocytes, which have a very short life and do not undergo subsequent cell divisions, need telomerase for their function.

Monocytes
There have been no studies of direct assessment of telomere length changes in monocytes with age. Several studies using PBMC consisting of 10–15% monocytes and 60–70% lymphocytes showed telomere shortening with age at a rate comparable with that of purified lymphocytes [38 , 40 , 60 ]. Like granulocytes, mature monocytes do not undergo further cell division after activation. Thus, the changes of telomere length in monocytes with age are likely reflecting the changes of telomere length in hematopoietic progenitor cells.

Mature monocytes do not express telomerase, but myeloid progenitor cells do appear to express telomerase. Studies of differentiation of a promyelocytic leukemia cell line (HL-60) in vitro demonstrated that telomerase is highly expressed in undifferentiated HL-60 cells but down-regulated after induced differentiation to monocytes or granulocytes [56 57 58 59 , 61 ]. The down-regulation of telomerase activity appears to be a differentiation process and is independent of cellular proliferation. These findings provide a direct link between telomerase activity and terminal differentiation and thus present a useful model to study regulation of telomerase activity in myeloid cells.

Mast cells
Like monocytes, no direct assessment of telomere length of mast cells with age has been shown, and no telomerase activity was detected in mature mast cells [62 ]. However, telomerase is expressed and regulated during mast-cell development from human hematopoietic pluripotent cells (CD34+) and mast-cell progenitor cells (CD34+/CD117+/CD13+) [62 ]. It has been shown that a rapid increase in telomerase activity preceded proliferation of hematopoietic stem- and mast-cell progenitors in the presence of stem-cell factor and IL-3 or IL-6. The induction of telomerase was transient, and telomerase activity declined to basal levels before the appearance of mature mast cells. These findings suggest that the transient induction of telomerase activity is dependent on growth factor-mediated signals in progenitor mast cells. The precise role of telomerase expression in progenitor mast-cell differentiation requires further study.


    CONCLUSION
 TOP
 ABSTRACT
 INTRODUCTION
 HEMATOPOIETIC STEM CELLS
 LYMPHOID LINEAGE
 MYELOID LINEAGE
 CONCLUSION
 REFERENCES
 
Leukocytes from lymphoid and myeloid lineages display similar characteristics and other distinct features in the regulation of telomere length and telomerase activity. Telomere attrition occurs with aging, and telomerase is highly expressed during development but is down-regulated after maturation of cells from lymphoid and myeloid lineages. Myeloid-derived cells are generally short-lived and do not express telomerase after maturation. However, lymphocytes, especially memory lymphocytes, are long-lived and express telomerase upon antigenic activation. Thus, telomerase may play important roles not only in progenitor cells of lymphoid and myeloid lineages but also in mature lymphocytes. Further studies will be necessary to discover the precise role of telomerase and its regulation of telomere length in progenitor as well as mature lymphoid and myeloid cells.


    ACKNOWLEDGEMENTS
 
The author thanks Richard Hodes for critically reading the manuscript and constructive suggestions and Arron Hieatt for proofreading the manuscript.

Received September 14, 2001; accepted September 18, 2001.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 HEMATOPOIETIC STEM CELLS
 LYMPHOID LINEAGE
 MYELOID LINEAGE
 CONCLUSION
 REFERENCES
 

  1. Jones, S. L., Lindberg, F. P., Brown, E. J. (1999) Phagocytosis Paul, W. E. eds. Fundamental Immunology ,997-1020 Lippincott-Raven Philadelphia.
  2. Melchers, F., Rolink, A. (1999) B-lymphocyte development and biology Paul, W. E. eds. Fundamental Immunology Philadelphia Lippincott-Raven.
  3. Benoist, C., Mathis, D. (1999) T-lymphocyte differentiation and biology Paul, W. E. eds. Fundamental Immunology ,367-410 Lippincott-Raven Philadelphia.
  4. Sprent, J., Surh, C. D. (2001) Generation and maintenance of memory T cells Curr. Opin. Immunol. 13,248-254[Medline]
  5. Harley, C. B. (1997) Human ageing and telomeres Ciba Found. Symp. 211,129-139[Medline]
  6. Greider, C. W., Blackburn, E. H. (1996) Telomeres, telomerase and cancer Sci. Am. 274,92-97[Medline]
  7. Blackburn, E. H. (2000) Telomere states and cell fates Nature 408,53-56[Medline]
  8. Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., Cech, T. R. (1997) Telomerase catalytic subunit homologs from fission yeast and human Science 277,955-959[Abstract/Free Full Text]
  9. Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., Bacchetti, S., Haber, D. A., Weinberg, R. A. (1997) hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization Cell 90,785-795[Medline]
  10. Feng, J., Funk, W. D., Wang, S. S., Weinrich, S. L., Avilion, A. A., Chiu, C. P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J. (1995) The RNA component of human telomerase Science 269,1236-1241[Abstract/Free Full Text]
  11. Morrison, S. J., Prowse, K. R., Ho, P., Weissman, I. L. (1996) Telomerase activity in hematopoietic cells is associated with self-renewal potential Immunity 5,207-216[Medline]
  12. Chiu, C. P., Dragowska, W., Kim, N. W., Vaziri, H., Yui, J., Thomas, T. E., Harley, C. B., Lansdorp, P. M. (1996) Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow Stem Cells 14,239-248[Abstract]
  13. Taylor, R. S., Ramirez, R. D., Ogoshi, M., Chaffins, M., Piatyszek, M. A., Shay, J. W. (1996) Detection of telomerase activity in malignant and nonmalignant skin conditions J. Investig. Dermatol. 106,759-765[Medline]
  14. Ramirez, R. D., Wright, W. E., Shay, J. W., Taylor, R. S. (1997) Telomerase activity concentrates in the mitotically active segments of human hair follicles J. Investig. Dermatol. 108,113-117[Medline]
  15. Broccoli, D., Young, J. W., de Lange, T. (1995) Telomerase activity in normal and malignant hematopoietic cells Proc. Natl. Acad. Sci. USA 92,9082-9086[Abstract/Free Full Text]
  16. Hiyama, K., Hirai, Y., Kyoizumi, S., Akiyama, M., Hiyama, E., Piatyszek, M. A., Shay, J. W., Ishioka, S., Yamakido, M. (1995) Activation of telomerase in human lymphocytes and hematopoietic progenitor cells J. Immunol. 155,3711-3715[Abstract]
  17. Miller, R. A. (1996) The aging immune system: primer and prospectus Science 273,70-74[Abstract]
  18. Globerson, A., Effros, R. B. (2000) Ageing of lymphocytes and lymphocytes in the aged Immunol. Today 21,515-521[Medline]
  19. Butcher, S., Chahel, H., Lord, J. M. (2000) Ageing and the neutrophil: no appetite for killing? Immunology 100,411-416[Medline]
  20. Globerson, A. (2001) Haematopoietic stem cell ageing Novartis Found. Symp. 235,85-96[Medline]
  21. Effros, R. B., Pawelec, G. (1997) Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion? Immunol. Today 18,450-454[Medline]
  22. Beverley, P. C., Grubeck-Loebenstein, B. (2000) Is immune senescence reversible? Vaccine 18,1721-1724[Medline]
  23. Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., Harley, C. B. (1992) Telomere length predicts replicative capacity of human fibroblasts Proc. Natl. Acad. Sci. USA 89,10114-10118[Abstract/Free Full Text]
  24. Wright, W. E., Piatyszek, M. A., Rainey, W. E., Byrd, W., Shay, J. W. (1996) Telomerase activity in human germline and embryonic tissues and cells Dev. Genet. 18,173-179[Medline]
  25. Vaziri, H., Dragowska, W., Allsopp, R. C., Thomas, T. E., Harley, C. B., Lansdorp, P. M. (1994) Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age Proc. Natl. Acad. Sci. USA 91,9857-9860[Abstract/Free Full Text]
  26. Engelhardt, M., Kumar, R., Albanell, J., Pettengell, R., Han, W., Moore, M. A. (1997) Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells Blood 90,182-193[Abstract/Free Full Text]
  27. Notaro, R., Cimmino, A., Tabarini, D., Rotoli, B., Luzzatto, L. (1997) In vivo telomere dynamics of human hematopoietic stem cells Proc. Natl. Acad. Sci. USA 94,13782-13785[Abstract/Free Full Text]
  28. Wynn, R. F., Cross, M. A., Hatton, C., Will, A. M., Lashford, L. S., Dexter, T. M., Testa, N. G. (1998) Accelerated telomere shortening in young recipients of allogeneic bone- marrow transplants Lancet 351,178-181[Medline]
  29. Wynn, R., Thornley, I., Freedman, M., Saunders, E. F. (1999) Telomere shortening in leucocyte subsets of long-term survivors of allogeneic bone marrow transplantation Br. J. Haematol. 105,997-1001[Medline]
  30. Lee, J., Kook, H., Chung, I., Kim, H., Park, M., Kim, C., Nah, J., Hwang, T. (1999) Telomere length changes in patients undergoing hematopoietic stem cell transplantation Bone Marrow Transplant 24,411-415[Medline]
  31. Rufer, N., Brummendorf, T. H., Chapuis, B., Helg, C., Lansdorp, P. M., Roosnek, E. (2001) Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation Blood 97,575-577[Abstract/Free Full Text]
  32. Mathioudakis, G., Storb, R., McSweeney, P. A., Torok-Storb, B., Lansdorp, P. M., Brummendorf, T. H., Gass, M. J., Bryant, E. M., Storek, J., Flowers, M. E., Gooley, T., Nash, R. A. (2000) Polyclonal hematopoiesis with variable telomere shortening in human long-term allogeneic marrow graft recipients Blood 96,3991-3994[Abstract/Free Full Text]
  33. Akiyama, M., Asai, O., Kuraishi, Y., Urashima, M., Hoshi, Y., Sakamaki, H., Yabe, H., Furukawa, T., Yamada, O., Mizoguchi, H., Yamada, H. (2000) Shortening of telomeres in recipients of both autologous and allogeneic hematopoietic stem cell transplantation Bone Marrow Transplant 25,441-447[Medline]
  34. Brummendorf, T. H., Rufer, N., Baerlocher, G. M., Roosnek, E., Lansdorp, P. M. (2001) Limited telomere shortening in hematopoietic stem cells after transplantation Ann. N. Y. Acad. Sci. 938,1-7[Abstract/Free Full Text]
  35. Yang, Z., Kodama, S., Suzuki, K., Watanabe, M. (1998) Telomerase activity, telomere length, and chromosome aberrations in the extension of life span of human embryo cells induced by low-dose X-rays J. Radiat. Res. (Tokyo) 39,35-51[Medline]
  36. Yui, J., Chiu, C. P., Lansdorp, P. M. (1998) Telomerase activity in candidate stem cells from fetal liver and adult bone marrow Blood 91,3255-3262[Abstract/Free Full Text]
  37. Weng, N. P., Levine, B. L., June, C. H., Hodes, R. J. (1995) Human naive and memory T lymphocytes differ in telomeric length and replicative potential Proc. Natl. Acad. Sci. USA 92,11091-11094[Abstract/Free Full Text]
  38. Son, N. H., Murray, S., Yanovski, J., Hodes, R. J., Weng, N. (2000) Lineage-specific telomere shortening and unaltered capacity for telomerase expression in human T and B lymphocytes with age J. Immunol. 165,1191-1196[Abstract/Free Full Text]
  39. Weng, N., Levine, B. L., June, C. H., Hodes, R. J. (1996) Regulated expression of telomerase activity in human T lymphocyte development and activation J. Exp. Med. 183,2471-2479[Abstract/Free Full Text]
  40. Rufer, N., Brummendorf, T. H., Kolvraa, S., Bischoff, C., Christensen, K., Wadsworth, L., Schulzer, M., Lansdorp, P. M. (1999) Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood J. Exp. Med. 190,157-167[Abstract/Free Full Text]
  41. Friedrich, U., Schwab, M., Griese, E. U., Fritz, P., Klotz, U. (2001) Telomeres in neonates: new insights in fetal hematopoiesis Pediatr. Res. 49,252-256[Medline]
  42. Vaziri, H., Schachter, F., Uchida, I., Wei, L., Zhu, X., Effros, R., Cohen, D., Harley, C. B. (1993) Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes Am. J. Hum. Genet. 52,661-667[Medline]
  43. Burns, J. B., Lobo, S. T., Bartholomew, B. D. (2000) In vivo reduction of telomere length in human antigen-reactive memory T cells Eur. J. Immunol. 30,1894-1901[Medline]
  44. Monteiro, J., Batliwalla, F., Ostrer, H., Gregersen, P. K. (1996) Shortened telomeres in clonally expanded CD28-CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts J. Immunol. 156,3587-3590[Abstract]
  45. Batliwalla, F. M., Rufer, N., Lansdorp, P. M., Gregersen, P. K. (2000) Oligoclonal expansions in the CD8(+)CD28(-) T cells largely explain the shorter telomeres detected in this subset: analysis by flow FISH Hum. Immunol. 61,951-958[Medline]
  46. Bodnar, A. G., Kim, N. W., Effros, R. B., Chiu, C. P. (1996) Mechanism of telomerase induction during T cell activation Exp. Cell Res. 228,58-64[Medline]
  47. Buchkovich, K. J., Greider, C. W. (1996) Telomerase regulation during entry into the cell cycle in normal human T cells Mol. Biol. Cell 7,1443-1454[Abstract]
  48. Igarashi, H., Sakaguchi, N. (1996) Telomerase activity is induced by the stimulation to antigen receptor in human peripheral lymphocytes Biochem. Biophys. Res. Commun. 219,649-655[Medline]
  49. Weng, N. P., Palmer, L. D., Levine, B. L., Lane, H. C., June, C. H., Hodes, R. J. (1997) Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging Immunol. Rev. 160,43-54[Medline]
  50. Maini, M. K., Soares, M. V., Zilch, C. F., Akbar, A. N., Beverley, P. C. (1999) Virus-induced CD8+ T cell clonal expansion is associated with telomerase up-regulation and telomere length preservation: a mechanism for rescue from replicative senescence J. Immunol. 162,4521-4526[Abstract/Free Full Text]
  51. Plunkett, F. J., Soares, M. V., Annels, N., Hislop, A., Ivory, K., Lowdell, M., Salmon, M., Rickinson, A., Akbar, A. N. (2001) The flow cytometric analysis of telomere length in antigen-specific CD8(+) T cells during acute Epstein-Barr virus infection Blood 97,700-707[Abstract/Free Full Text]
  52. Weng, N. P., Granger, L., Hodes, R. J. (1997) Telomere lengthening and telomerase activation during human B cell differentiation Proc. Natl. Acad. Sci. USA 94,10827-10832[Abstract/Free Full Text]
  53. Igarashi, H., Sakaguchi, N. (1997) Telomerase activity is induced in human peripheral B lymphocytes by the stimulation to antigen receptor Blood 89,1299-1307[Abstract/Free Full Text]
  54. Hu, B. T., Lee, S. C., Marin, E., Ryan, D. H., Insel, R. A. (1997) Telomerase is up-regulated in human germinal center B cells in vivo and can be re-expressed in memory B cells activated in vitro J. Immunol. 159,1068-1071[Abstract]
  55. Robertson, J. D., Gale, R. E., Wynn, R. F., Dougal, M., Linch, D. C., Testa, N. G., Chopra, R. (2000) Dynamics of telomere shortening in neutrophils and T lymphocytes during ageing and the relationship to skewed X chromosome inactivation patterns Br. J. Haematol. 109,272-279[Medline]
  56. Xu, D., Gruber, A., Peterson, C., Pisa, P. (1996) Supression of telomerase activity in HL60 cells after treatment with differentiating agents Leukemia 10,1354-1357[Medline]
  57. Bestilny, L. J., Brown, C. B., Miura, Y., Robertson, L. D., Riabowol, K. T. (1996) Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines Cancer Res 56,3796-3802[Abstract/Free Full Text]
  58. Savoysky, E., Yoshida, K., Ohtomo, T., Yamaguchi, Y., Akamatsu, K., Yamazaki, T., Yoshida, S., Tsuchiya, M. (1996) Down-regulation of telomerase activity is an early event in the differentiation of HL60 cells Biochem. Biophys. Res. Commun. 226,329-334[Medline]
  59. Holt, S. E., Wright, W. E., Shay, J. W. (1996) Regulation of telomerase activity in immortal cell lines Mol. Cell. Biol. 16,2932-2939[Abstract]
  60. Iwama, H., Ohyashiki, K., Ohyashiki, J. H., Hayashi, S., Yahata, N., Ando, K., Toyama, K., Hoshika, A., Takasaki, M., Mori, M., Shay, J. W. (1998) Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals Hum. Genet. 102,397-402[Medline]
  61. Sharma, H. W., Maltese, J. Y., Zhu, X., Kaiser, H. E., Narayanan, R. (1996) Telomeres, telomerase and cancer: is the magic bullet real? Anticancer Res 16,511-515[Medline]
  62. Chaves-Dias, C., Hundley, T. R., Gilfillan, A. M., Kirshenbaum, A. S., Cunha-Melo, J. R., Metcalfe, D. D., Beaven, M. A. (2001) Induction of telomerase activity during development of human mast cells from peripheral blood cd34(+) cells: comparisons with tumor mast-cell lines J. Immunol. 166,6647-6656[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
A. Ujike-Asai, A. Okada, Y. Du, M. Maruyama, X. Yuan, F. Ishikawa, Y. Motoo, K. Isobe, and H. Nakajima
Large defects of type I allergic response in telomerase reverse transcriptase knockout mice
J. Leukoc. Biol., August 1, 2007; 82(2): 429 - 435.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
C-H. Wu, S-C. Hsieh, K-J. Li, M-C. Lu, and C-L. Yu
Premature telomere shortening in polymorphonuclear neutrophils from patients with systemic lupus erythematosus is related to the lupus disease activity
Lupus, April 1, 2007; 16(4): 265 - 272.
[Abstract] [PDF]


Home page
Int J EpidemiolHome page
A. Aviv, A. M Valdes, and T. D Spector
Human telomere biology: pitfalls of moving from the laboratory to epidemiology
Int. J. Epidemiol., December 1, 2006; 35(6): 1424 - 1429.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
L. Ping, A. Asai, A. Okada, K. Isobe, and H. Nakajima
Dramatic increase of telomerase activity during dendritic cell differentiation and maturation
J. Leukoc. Biol., August 1, 2003; 74(2): 270 - 276.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weng, N.-p.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weng, N.-p.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS